Medscape www.medscape.com

References for:
Analgesics

[Curr Med Res Opin 17(1s):s13-s16, 2001. © 2001 Librapharm Limited]

  1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231: 232-4
  2. Limmroth V, Katsarava Z, Diener H-C. Acetylsalicylic acid in the treatment of headache. Cephalalgia 1999;19:545-51
  3. Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 1975;2:57-63
  4. Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 1984;4:107-11
  5. Tfelt-Hansen P, Olesen J. Paracetamol (acetaminophen) versus acetylsalicyclic acid in migraine. Eur Neurol 1980;4: 107-11
  6. Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeuillerie G. Double-blind comparison of an acetaminophen 400 mg - codeine 25 mg combination versus aspirin 1 000 mg and placebo in acute migraine attack. Cephalalgia 1994;14:156-61
  7. Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein S, Sheftell F. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain - three double-blind, randomized, placebo-controlled trials. Arch Neurol 1998;55:210-17
  8. Silberstein SD, Armellino JJ, Hoffman HD, Battikha JP, Hamelsky SW, Stewart WF, et al. Treatment of menstruation- associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther 1999;21:475-91
  9. Pilgrim AJ. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol 1991;31:295-9
  10. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 1992;32:177-84
  11. Chabriat H, Danchot J, Grippon P, Bousser MG. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicenter doubleblind placebo-controlled study. Cephalalgia 1994;14:297- 300
  12. Tfelt-Hansen P, Henry P, Mulder LJ, Schaeldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995;346:923-6
  13. Noda S, ltho H, Umezaki H. Successful treatment of migraine attacks with intravenous injection of aspirin. J Neurol Neurosurg Psychiatry 1985;48:1257-62
  14. Limmroth V, May A, Diener HC. Lysine-acetylsalicylic acid in acute migraine attacks. Eur Neurol 1999;41:88-93
  15. Diener HC, for the ASASUMAMIG Study Group. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. Cephalalgia 1999;19:581-8
  16. Hakkarainen H, Vapaatalo H, Gothoni G, Paratainen J. Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet 1979;ii:326-7
  17. Tokola RA, Kangasniemi P, Neuvonen PJ, Tokola O. Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks. Cephalalgia 1984;4:253-63
  18. Larsen BH, Christiansen LV, Andersen B, Olesen J. Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine. Acta Neurol Scand 1990;81:464-7
  19. Myllyia VV, Havanka H, Herrala L, Kangasniemi P, Rautakorpi I, Turkka J, et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache 1998;38:201-7
  20. Andersson PG, Hinge HH, Johansen 0, Andersen CU, Lademann A, Gotzsche PC. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks. Cephalalgia 1989;9:29-32
  21. Nestvold K, Kloster R, Partinen MSR. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 1985;5:115-19
  22. Treves TA, Korczyn AD, Streifler M. Naproxen versus ergotamine in the treatment of acute migraine attacks. Headache 1992;32:280-2
  23. Pradalier A, Rancurel G, Dordain G, Verdure L, Rascol A, Dry J. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia 1985;5:107-13
  24. Saadah HA. Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine. Headache 1992;32:95-7
  25. Sargent JD, Baumel B, Peters K, Diamond S, Saper JR, Eisner LS, et al. Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine. Headache 1988;28: 263-6
  26. Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990;30:705-9
  27. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache 1989; 29:507-9
  28. Nebe J, Heier M, Diener HC. Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995; 15:531-5
  29. Pearce I, Frank GJ, Pearce JMS. lbuprofen compared with paracetamol in migraine. Practitioner 1983;227:465-7
  30. Kangasniemi P, Kaaja R. Ketoprofen and ergotamine in acute migraine. J Int Med 1992;231:551-4
  31. Karabetsos A, Karachalios G, Bourlinou P, Reppa A, Koutri R, Fotiadou A. Ketoprofen versus paracetamol in the treatment of acute migraine. Headache 1997;37:12-14
  32. Guidotti M, Zanasi S, Garagiola U. Pirprofen in the treatment of migraine and episodic headache attacks: a placebo-controlled crossover clinical trial. J Int Med Res 1989;17:48-54
  33. Kinnunen E, Erkinjuntti TF, Palomtäki H, Porras J, Teirmaa H, Freudenthal Y, et al. Placebo-controlled double- blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks. Cephalalgia 1988;8:175-9
  34. Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF, et al. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 2000;20:233-43
  35. Dahlöf C, Björkman R. Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine. Cephalalgia 1993;13:117-23
  36. Karachalios GN, Fotiadou A, Chrisikos N, Karabetsos A, Kehagioglou K. Treatment of acute migraine attack with diclofenac sodium: a double-blind study. Headache 1992; 32:98-100
  37. The Diclofenac-K/Sumatriptan Migraine Study Group. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal antiinflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia 1999;19:232-40
  38. MacGregor EA, Wilkinson M, Bancroft K. Domperidone plus paracetamol in the treatment of migraine. Cephalalgia 1993;13:124-7
  39. Gawel MJ, Szalai JF, Stiglick A, Weiner M. Evaluation of analgesic agents in recurring headache compared with other clinical pain models. Clin Pharmacol Ther 1990;47:504-8
  40. Somerville BW. Treatment of migraine attacks with an analgesic combination. Med J Aust 1976;1:865-6
  41. Adam EI. A treatment for the acute migraine attack. J lnt Med Res 1987;15:71-4
  42. Carasso RL, Yehufda S. The prevention and treatment of migraine with an analgesic combination. Br J Clin Pract 1984;38:25-7
  43. Uzogara E, Sheehan DV, Manschreck TC, Jones KJ. A combination treatment for acute common migraine. Headache 1986;26:231-6
  44. Diamond S, Freitag FG, Diamond ML, Urban G. Transnasal butorphanol in the treatment of migraine headache pain. Headache Q 1992;3:164-71
  45. Hoffert MJ, Couch JR, Diamond S, Eikind AH, Goldstein J, Kohlerman NJ, et al. Transnasal butorphanol in the treatment of acute migraine. Headache 1995;35:65-9